Corient Private Wealth’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $66.4M | Buy |
599,256
+2,204
| +0.4% | +$244K | 0.07% | 217 |
|
|
2025
Q1 | $66.9M | Sell |
597,052
-35,751
| -6% | -$4.01M | 0.11% | 183 |
|
|
2024
Q4 | $58.5M | Buy |
632,803
+1,163
| +0.2% | +$107K | 0.1% | 201 |
|
|
2024
Q3 | $53M | Sell |
631,640
-27,997
| -4% | -$2.35M | 0.08% | 229 |
|
|
2024
Q2 | $45.3M | Sell |
659,637
-35,385
| -5% | -$2.43M | 0.08% | 236 |
|
|
2024
Q1 | $50.9M | Sell |
695,022
-31,957
| -4% | -$2.34M | 0.09% | 219 |
|
|
2023
Q4 | $58.9M | Sell |
726,979
-32,851
| -4% | -$2.66M | 0.11% | 193 |
|
|
2023
Q3 | $56.9M | Sell |
759,830
-17,414
| -2% | -$1.31M | 0.13% | 169 |
|
|
2023
Q2 | $59.9M | Buy |
777,244
+257,810
| +50% | +$19.9M | 0.14% | 156 |
|
|
2023
Q1 | $43.1M | Buy |
519,434
+166,913
| +47% | +$13.8M | 0.12% | 174 |
|
|
2022
Q4 | $30.3M | Buy |
+352,521
| New | +$30.3M | 0.11% | 199 |
|